Chief of Allergy, Asthma & Immunology for Advocate Health Centers of Advocate Health Care, one of the largest integrated healthcare networks in the United States. He has also served as Associate Director of Allergy and Immunology at Hahnemann University Medical Center and School of Medicine in Philadelphia, Pennsylvania.
Dr. Foggs is a member of the Expert Panel 3 of the National Asthma Education Prevention Program/National Heart, Lung, and Blood Institute, responsible for writing the 2007 EPR-3: Guidelines for the Diagnosis and Management of Asthma. He is also a member of the US Food and Drug Administration’s Pulmonary-Allergy Drug Advisory Committee.
Dr. Foggs is Chair of the Managed Care & Health Plans Committee of the American College of Allergy, Asthma & Immunology (ACAAI). He is a member of the Board of Directors of the Joint Council of Allergy, Asthma and Immunology (JCAAI) and an immediate-past member of the ACAAI Board of Regents. He also chairs the ACAAI Credentials Committee and serves on the Marketing Task Force, Membership, Recruitment, and Public Relations Committees.
With the American Academy of Allergy, Asthma and Immunology (AAAAI), Dr. Foggs sits on the Committee on the Underserved; Odyssey Faculty & Underserved Task Force; the Health Outcomes, Education, Delivery & Quality (HEDQ) Committee; and Plenary Subcommittee.
He is Immediate-past Chair of the Allergy, Asthma & Immunology Section of the National Medical Association (NMA) and a member of NMA’s Consensus Panel on Asthma in the African American Community and the Task Force on Pay for Performance.
Dr. Foggs is a past member of the Government Relations Committee of the American College of Chest Physicians (ACCP). He is a member of the Asthma Special Committee of the World Allergy Organization (WAO). Dr. Foggs is a member of the Asthma Workgroup of the American Board of Medical Specialties. He serves on the editorial board of the Annals of Allergy, Asthma & Immunology and is a reviewer for several journals.
He graduated from Yale University with a Bachelor of Science degree in biology and cellular ultrastructure. Dr. Foggs earned his medical degree at Harvard Medical School, completed his internship and residency in internal medicine at Northwestern University Medical Center and his postdoctoral fellowship in allergy and immunology as a National Institutes of Health Scholar at the University of Pennsylvania School of Medicine.
Dr. Foggs’s statement:
NAEPP Guidelines-level care must be made available to all individuals with asthma.
Despite progressive advances made in the past twenty years in asthma research, much of which is included in the 2007 NAEPP/NHLBI Guidelines for the Diagnosis and Management of Asthma, there has been no major improvement in asthma morbidity and mortality among inner-city dwellers.
These patients are most often unknowingly denied access to these nationally established evidence-based practice standards for appropriate asthma management, through restricted formularies and restricted access to asthma specialists. Yet they are at the greatest risk of death and suffer the highest physical, financial and emotional burden of asthma. They have no chance of breaking the cycle of chronic disease until we fix a broken system and provide access to NAEPP Guidelines-level care, which includes access to medications and to specialty care without discrimination.
If we want to reduce morbidity and mortality and the associated excessive costs of poorly controlled asthma in our country, this is where we must start.
Restricted access to appropriate asthma medications and to asthma specialists ultimately increases resource utilization when the patient turns to the Emergency Department as an outpatient clinic and when preventable asthma exacerbations lead to preventable hospitalizations.
Formal asthma education programs must be integrated into school curricula to teach students with asthma, and their families, how to manage asthma and how to avoid or eliminate asthma triggers.
Doctors who care for inner-city patients with asthma must be regularly updated on how to develop and deliver appropriate asthma management strategies using the NAEPP guidelines. We know this care saves lives, eliminates suffering and reduces healthcare expenditures. It’s time to put it in place for all patients.
If we are to experience true healthcare reform, we must understand that the current model for asthma care among Medicaid and Medicare patients is broken. We know how to fix it and we need your help.
New healthcare reform legislation must include facilitating access to NAEPP Guidelines-level quality asthma care and eliminate political and policy barriers that limit patient access to appropriate and available asthma medications and specialty care.